Introduction of DMPA-SC self-injection in Ghana: A feasibility and acceptability study using Sayana® Press [PDF]
This research report describes results from an implementation science study that explored the feasibility and acceptability of administering depot medroxyprogesterone acetate-subcutaneous (DMPA-SC) among health-care providers and family planning (FP ...
Dela Nai +6 more
openaire +3 more sources
Patterns of triggers, ideation and motivational factors of contraceptive utilization among women and gate-keepers in Nigeria: a scoping study on the resilient and accelerated scale up of DMPA-SC in Nigeria (RASUDIN) [PDF]
Background Women have unfair share in the burden of unintended pregnancy outcome and unhealthy interpregnancy intervals. An understanding of the triggers, ideation and motivational factors influencing utilization of modern contraceptives is relevant for ...
Kehinde Osinowo +4 more
doaj +2 more sources
DMPA-SC self-injection experiences of clients and providers in Uganda: the role of community health workers in reproductive self-care service delivery [PDF]
Accelerating task sharing for family planning and contraceptive self-care can minimize the impact of a projected shortage of 18 million health care workers by 2030.
Jane Cover +5 more
doaj +2 more sources
Patient satisfaction of depot medroxyprogesterone acetate (dmpa-sc) injection as contraceptive.
To determine Patient Satisfaction of DMPA-SC (104 mg/0.65 mL) injected subcutaneously once every 3 months.It was a Descriptive case series with the centre in Rawalpindi (Holy Family Hospital, Gynecology and Obstetrics Unit), Pakistan. Twenty five patients were selected by purposive sampling and followed up in Rawalpindi center (Holy Family Hospital ...
Rizwana, Chaudhri +2 more
openaire +2 more sources
Consistency of on-the-job training implementation for subcutaneous depot medroxyprogesterone acetate in Ghana and associated healthcare worker knowledge transfer: A cross-sectional mixed-methods study. [PDF]
Subcutaneous depot medroxyprogesterone acetate, or DMPA-SC, is an injectable contraceptive that can be administered by any trained person, including for self-injection.
Chelsey Porter Erlank +6 more
doaj +2 more sources
Efficacy and patient satisfaction with Sayana Press (DMPA-SC) among women seeking birth spacing
Objectives: To determine the efficacy of depot medroxyprogesterone acetate subcutaneous injection in females seeking birth-spacing, and to evaluate patient satisfaction. Method: The descriptive case series was conducted at the Department of Obstetrics
Saman Asghar +5 more
doaj +3 more sources
Background To increase access to voluntary family planning (FP) services, Nigerian policymakers are debating how to task share injectable contraceptive services to drug shop owners known as Patent and Proprietary Medicine Vendors (PPMVs). Task sharing FP
Sara Chace Dwyer +6 more
doaj +2 more sources
Quality of counseling for self-administering injectable contraception: field evidence from mystery client interactions in Lagos, Nigeria [PDF]
Background Self-injection (SI) of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is a self-care intervention (drugs, diagnostics, or devices that can be provided mostly outside the health system) implemented across Nigeria.
Sneha Challa +11 more
doaj +2 more sources
Acceptability and effectiveness of empathy-based provider training and community-level awareness activities on self-injectable contraceptive use in Niger, Lagos, and Oyo States, Nigeria: a mixed methods program evaluation [PDF]
Background Interventions aimed to increase healthcare provider empathy and capacity to deliver person-centered care have been shown to improve healthcare seeking and outcomes.
Susan Ontiri +9 more
doaj +2 more sources
Body weight and bleeding pattern changes in women using DMPA-SC.
To determine the 1-year efficacy of contraception, changes in bleeding pattern and weight with the use of Depot medroxyprogesterone acetate-subcutaneous injected subcutaneously once every 3 months.Descriptive case-series.Gynaecology and Obstetrics Unit, Holy Family Hospital, Rawalpindi, from March 2003 to June 2004.Twenty five patients were selected by
Rizwana, Chaudhri +2 more
openaire +2 more sources

